Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

1. Friedlander, M.
2. Moore, K.N.
3. Colombo, N.
4. Scambia, G.
5. Kim, B.-G.
6. Oaknin, A.
7. Lisyanskaya, A.
8. Sonke, G.S.
9. Gourley, C.
10. Banerjee, S.
11. Oza, A.
12. González-Martín, A.
13. Aghajanian, C.
14. Bradley, W.H.
15. Liu, J.
16. Mathews, C.
17. Selle, F.
18. Lortholary, A.
19. Lowe, E.S.
20. Hettle, R.
21. Flood, E.
22. Parkhomenko, E.
23. DiSilvestro, P.